Moderna Stock Surges on $1.5 Billion Coronavirus Vaccine Deal with the U.S. Government
The United States of America is building its arsenal for the battle against COVID-19.
The U.S. government has struck a blockbuster deal with Moderna (NASDAQ: MRNA) that will allow it to secure 100 million doses of the biotech company's experimental coronavirus vaccine, labeled mRNA-1273, for $1.525 billion, should it prove both safe and effective. The deal, announced Tuesday, will also give the U.S. the option to acquire an additional 400 million doses.
The U.S. is partnering with Moderna to ramp up its coronavirus defenses. Image source: Getty Images.
Source Fool.com
